Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
28.21
+0.10 (0.36%)
Jun 27, 2025, 4:00 PM - Market closed
Fresenius Medical Care AG Employees
Fresenius Medical Care AG had 111,513 employees as of December 31, 2024. The number of employees decreased by 8,332 or -6.95% compared to the previous year.
Employees
111,513
Change (1Y)
-8,332
Growth (1Y)
-6.95%
Revenue / Employee
$188,936
Profits / Employee
$5,992
Market Cap
16.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 111,513 | -8,332 | -6.95% |
Dec 31, 2023 | 119,845 | -8,199 | -6.40% |
Dec 31, 2022 | 128,044 | 5,135 | 4.18% |
Dec 31, 2021 | 122,909 | -2,455 | -1.96% |
Dec 31, 2020 | 125,364 | 4,705 | 3.90% |
Dec 31, 2019 | 120,659 | 8,001 | 7.10% |
Dec 31, 2018 | 112,658 | -1,342 | -1.18% |
Dec 31, 2017 | 114,000 | 4,681 | 4.28% |
Dec 31, 2016 | 109,319 | 5,286 | 5.08% |
Dec 31, 2015 | 104,033 | 4,138 | 4.14% |
Dec 31, 2014 | 99,895 | 9,205 | 10.15% |
Dec 31, 2013 | 90,690 | 4,537 | 5.27% |
Dec 31, 2012 | 86,153 | 6,994 | 8.84% |
Dec 31, 2011 | 79,159 | 5,707 | 7.77% |
Dec 31, 2010 | 73,452 | 5,464 | 8.04% |
Dec 31, 2009 | 67,988 | 3,322 | 5.14% |
Dec 31, 2008 | 64,666 | 3,260 | 5.31% |
Dec 31, 2007 | 61,406 | 4,603 | 8.10% |
Dec 31, 2006 | 56,803 | 9,282 | 19.53% |
Dec 31, 2005 | 47,521 | 2,995 | 6.73% |
Dec 31, 2004 | 44,526 | 3,429 | 8.34% |
Dec 31, 2003 | 41,097 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FMS News
- 11 days ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 12 days ago - Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs - WSJ
- 12 days ago - Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - PRNewsWire
- 12 days ago - Fresenius Medical Care announces 1 bln euros share buyback programme - Reuters
- 12 days ago - 5 Stocks To Ride The German Market Rally - Benzinga
- 25 days ago - Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. - PRNewsWire
- 4 weeks ago - Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025 - PRNewsWire
- 5 weeks ago - Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - PRNewsWire